American Society For Transplantation And Cellular Therapy

BRIEF

published on 11/11/2024 at 18:05, 1 month 9 days ago

2025 Tandem Meetings to Convene Experts in Hawai'i

Tandem Meetings Hematopoietic Cell Transplantation Medical Advancements Cellular And Gene Therapy ASTCT And CIBMTR
PRESS RELEASE

published on 11/11/2024 at 18:00, 1 month 9 days ago

The Tandem Meetings of ASTCT and CIBMTR Return to Hawai'i From February 12-15, 2025
ASTCT and CIBMTR unite leading experts at the Tandem Meetings to share advancements in HCT, cellular therapy, and gene therapy with a global community of professionals. Event highlights latest scientific updates and innovative technologies

Cellular Therapy Gene Therapy Tandem Meetings HCT Scientific Updates
BRIEF

published on 08/15/2024 at 19:05, 4 months 5 days ago

FDA Approves Axatilimab-Csfr for Chronic Graft-Versus-Host Disease

FDA Approval ASTCT Axatilimab-csfr CGVHD Treatment AGAVE-201 Study
PRESS RELEASE

published on 08/15/2024 at 19:00, 4 months 5 days ago

ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
ASTCT applauds FDA approval of Niktimvo by Incyte Corporation for cGVHD treatment. Study confirms efficacy and potential benefits for patients. ASTCT remains committed to advancing transplantation field

FDA Approval ASTCT Transplantation CGVHD Treatment Niktimvo
BRIEF

published on 08/02/2024 at 22:15, 4 months 18 days ago

FDA Approves TECELRA for Synovial Sarcoma Treatment

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
PRESS RELEASE

published on 08/02/2024 at 22:10, 4 months 18 days ago

American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment
The FDA's accelerated approval of TECELRA marks a milestone in cancer treatment. ASTCT supports this advance in cellular therapy for synovial sarcoma patients

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
BRIEF

published on 04/10/2024 at 16:05, 8 months 10 days ago

ASTCT Endorses FDA's New CAR T-Cell Therapy Approvals for Multiple Myeloma

FDA Approval Medical Innovation Multiple Myeloma CAR T-cell Therapy ASTCT Endorsement
PRESS RELEASE

published on 04/10/2024 at 16:00, 8 months 10 days ago

ASTCT Supports the FDA's Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma
FDA approves expanded use of CAR T-Cell therapies Abecma and Carvykti for multiple myeloma treatment, supported by ASTCT. Decision based on FDA and ODAC recommendations

FDA Approval Multiple Myeloma CAR T-cell Therapy ASTCT Support Disease Intervention
BRIEF

published on 03/22/2024 at 16:05, 8 months 29 days ago

Medicare Expands Stem Cell Transplant Coverage for Myelodysplastic Syndromes

Medicare Stem Cell Transplantation Health Policy Myelodysplastic Syndromes National Coverage Determination
PRESS RELEASE

published on 03/22/2024 at 16:00, 8 months 29 days ago

The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation
CMS revises National Coverage Determination for allogeneic HSCT in MDS patients following requests from ASH, ASTCT, NMDP, and CIBMTR. Updated ruling expands Medicare coverage for life-saving treatment

National Coverage Determination CMS Allogeneic HSCT MDS Patients Medicare Coverage

Published on 12/21/2024 at 01:30, 12 hours 16 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 16 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 41 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 46 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 16 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 54 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 35 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 49 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 45 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 28 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 46 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 51 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 23 hours 46 minutes ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News